Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis.
Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options.
Certified occupational therapy assistants.
Connexin 43 astrocytopathy linked to rapidly progressive multiple sclerosis and neuromyelitis optica.
Blood Plasma Levels of Microelements in Patients with History of Optic Neuritis.
Impaired toll-like receptor 8 signaling in multiple sclerosis.
Environmental factors acting during development to influence MS risk: insights from animal studies.
Benefits, safety, and prescription of exercise in persons with multiple sclerosis.
The impact of slower walking speed on activities of daily living in patients with multiple sclerosis.
Altered topological organization of white matter structural networks in patients with neuromyelitis optica.
Reduced fingolimod dosage treatment for patients with multiple sclerosis and lymphopenia or neutropenia.
EXPRESSION OF CONCERN: The American Academy of Neurology's Top Five Choosing Wisely recommendations.
B-Cell Targeting Agents in the Treatment of Multiple Sclerosis.
Point prevalence and correlates of depression in a national community sample with multiple sclerosis.
Involvement of aquaporin 4 in astrocyte function and neuropsychiatric disorders.
Evaluating the Role of Coping Style as a Moderator of Fatigue and Risk for Future Cognitive Impairment in Multiple Sclerosis.
Vitamin D supplementation, moderate sun exposure, and control of immune Diseases.
Epstein-Barr virus neuraxis infection as a trigger for central nervous system demyelinating processes: a case report.
Tumefactive demyelination presenting during bevacizumab treatment.
Polyclonal immunoglobulin G for autoimmune demyelinating nervous system disorders.
Frequency analysis approach to study balance control in individuals with multiple sclerosis.
Cell-Based Reporter Gene Assay for Therapy-Induced Neutralizing Antibodies to Interferon-Beta in Multiple Sclerosis.
Co-morbid Guillain-Barre syndrome and acute disseminated encephalomyelitis.
Expression, purification, crystallization and preliminary X-ray crystallographic analysis of the extracellular olfactomedin domain of gliomedin.
Cardiorespiratory fitness and its association with thalamic, hippocampal, and basal ganglia volumes in multiple sclerosis.
Pages
« first
‹ previous
…
407
408
409
410
411
412
413
414
415
…
next ›
last »